Transcatheter tricuspid valve repair and replacement

Series
Cardiovascular
Status
Published
Date
Number of report
09

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for minimally invasive tricuspid valve repair and replacement procedures. The procedures performed via endovascular and transapical approach are considered.

Reimbursement analysis will cover the following procedures:

  • transcatheter tricuspid valve repair;
  • transcatheter tricuspid valve replacement.

The diagnosis of nonrheumatic tricuspid (valve) insufficiency is considered as an indication for procedures.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Table of content is not available at the moment. Report is still ongoing.

(we accept only company emails)